Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
MBNL overexpression rescues cardiac phenotypes in a myotonic dystrophy type 1 heart mouse model
Rong-Chi Hu, … , Zheng Xia, Thomas A. Cooper
Rong-Chi Hu, … , Zheng Xia, Thomas A. Cooper
Published February 11, 2025
Citation Information: J Clin Invest. 2025;135(7):e186416. https://doi.org/10.1172/JCI186416.
View: Text | PDF
Research Article Genetics Article has an altmetric score of 73

MBNL overexpression rescues cardiac phenotypes in a myotonic dystrophy type 1 heart mouse model

  • Text
  • PDF
Abstract

Myotonic dystrophy type 1 (DM1) is an autosomal dominant disease caused by a CTG repeat expansion in the dystrophia myotonica protein kinase (DMPK) gene. The expanded CUG repeat RNA (CUGexp RNA) transcribed from the mutant allele sequesters the muscleblind-like (MBNL) family of RNA-binding proteins, causing their loss of function and disrupting regulated pre-mRNA processing. We used a DM1 heart mouse model that inducibly expresses CUGexp RNA to test the contribution of MBNL loss to DM1 cardiac abnormalities and explored MBNL restoration as a potential therapy. AAV9-mediated overexpression of MBNL1 and/or MBNL2 significantly rescued DM1 cardiac phenotypes including conduction delays, contractile dysfunction, hypertrophy, and misregulated alternative splicing and gene expression. While robust, the rescue was partial compared with reduced CUGexp RNA and plateaued with increased exogenous MBNL expression. These findings demonstrate that MBNL loss is a major contributor to DM1 cardiac manifestations and suggest that additional mechanisms play a role, highlighting the complex nature of DM1 pathogenesis.

Authors

Rong-Chi Hu, Yi Zhang, Larissa Nitschke, Sara J. Johnson, Ayrea E. Hurley, William R. Lagor, Zheng Xia, Thomas A. Cooper

×

Figure 6

MBNL1 and/or MBNL2 overexpression results in partial rescue for widespread DGE in ventricles of CUG960 +dox mice.

Options: View larger image (or click on image) Download as PowerPoint
MBNL1 and/or MBNL2 overexpression results in partial rescue for widespre...
(A) Gene signature scores for ventricular samples. The center line represents the median value, while the upper and lower dashed lines indicate the first and third quartiles. (B) Differentially expressed genes displaying at least a 1.5-fold change (adjusted P = 0.05) as compared with expression in CUG960 +dox controls. (C) Percentages of overlapping DGE in each MBNL-overexpressing cohort using the comparison between CUG960 +/-dox and +dox cohorts as a reference. (D) GO functional terms for genes showing DGE changes in the ventricles of mice in all cohorts. Dashed line: –log10(FDR) = 1.5. (E–G) RT-qPCR–based validation of candidate genes showing gene expression changes in ventricles of mice in each cohort. Rpl4 was used as an internal control for normalization. n = 3 animals per cohort. Black lines indicate the significant differences in corresponding groups compared with +dox or tdTomato controls; brown lines indicate the significant differences between the corresponding groups and +/–dox and –dox controls. Data represent the mean ± SEM. *P < 0.05, **P < 0.01, ***P < 0.001, and ****P < 0.0001, by ordinary 1-way ANOVA followed by Tukey’s multiple-comparison test. Reg., regulation.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Picked up by 9 news outlets
Blogged by 2
Posted by 1 X users
Referenced by 3 Bluesky users
6 readers on Mendeley
See more details